Ismet Aydogdu

508 citations
27 papers · 370 indexed · h-index 11
Topics
Eosinophilic Disorders and Syndromes (3 papers)Hemoglobinopathies and Related Disorders (3 papers)Chronic Lymphocytic Leukemia Research (2 papers)

In The Last Decade

Ismet Aydogdu

27 papers receiving 355 citations

Peers

Ismet Aydogdu
Comparison fields: 5 of 69
  • Hematology 93
  • Pulmonary and Respiratory Medicine 78
  • Immunology 74
  • Oncology 61
  • Genetics 60
Replace F Streiff with:
F Streiff France
Hongyan Li China
Muhammed Sherid United States
William H. Kammerer United States
Michaël Bismuth France
Craig W. Freyer United States
Arnoud Loof Netherlands
J. Sarles France
Mathias Schneeweiss‐Gleixner Austria
Yuko Kanbayashi Japan
Ismet Aydogdu relative to F Streiff France F Streiff's profile →
Citations per field
00.5×10×
F Streiff · 1×
Citations per year

Countries citing papers authored by Ismet Aydogdu

Since Specialization
Citations

This map shows the geographic impact of Ismet Aydogdu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ismet Aydogdu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ismet Aydogdu more than expected).

Fields of papers citing papers by Ismet Aydogdu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ismet Aydogdu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ismet Aydogdu. The network helps show where Ismet Aydogdu may publish in the future.

Co-authorship network of co-authors of Ismet Aydogdu

This figure shows the co-authorship network connecting the top 25 collaborators of Ismet Aydogdu. A scholar is included among the top collaborators of Ismet Aydogdu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ismet Aydogdu. Ismet Aydogdu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 6
2 6
3 48
4 8
5 32
6 8
7 10
8 2
9 1
10 38
11 49
12 30
13 8
14 13
15 2
16 5
17 8
18 16
19 5
20 6

About Ismet Aydogdu

Ismet Aydogdu is a scholar working on Hematology, Genetics and Dermatology, having authored 27 papers that have together received 370 indexed citations. Recurring topics across this work include Eosinophilic Disorders and Syndromes (3 papers), Hemoglobinopathies and Related Disorders (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Hematology (93 citations), Genetics (60 citations) and Dermatology (37 citations). Ismet Aydogdu has collaborated with scholars based in Türkiye, United States and Taiwan. Frequent co-authors include Emın Kaya, İrfan Kuku, Mehmet Ali Erkurt, A. Sevinç, Ömer Akyol, Nilüfer Bayraktar, Süleyman Özen, Nihayet Bayraktar, Ferah Armutçu and Mustafa Iraz. Their work appears in journals such as British Journal of Haematology, Journal of Surgical Research and Journal of the European Academy of Dermatology and Venereology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026